KMT2C and breast carcinoma: Genome sequencing has allowed us to identify several somatic mutations in MLL3 found in many diseases, such as non-Hodgkin’s lymphoma [23], bladder cancer [24], breast cancer [14], medulloblastoma [25], acute myeloid leukemia [26], and epithelial lymphoma T cells [27].